Preview

Transbaikalian Medical Bulletin

Advanced search

COCKAYNE SYNDROME TYPE II

https://doi.org/10.52485/19986173_2025_4_147

Abstract

Cockayne syndrome (CS) is a rare autosomal recessive neurodegenerative disorder associated with impaired DNA repair, developmental delay, and multisystem involvement. This article presents a rare clinical case of type II CS in a child with a confirmed ERCC6 gene mutation and a severe disease course. Symptoms manifested in the neonatal period and progressed with profound neurological deficits, sensorineural hearing loss, ophthalmologic disorders, epileptic syndrome, and persistent malnutrition. A distinctive feature of this case is the unusually long survival (up to 17 years), which is exceptional for CS type II, typically associated with a poor prognosis. The diagnosis was confirmed by molecular genetic testing, and neuroimaging revealed characteristic brain abnormalities. The patient received supportive care based on a multidisciplinary approach, including nutritional, symptomatic, antiepileptic, and palliative treatment. The condition remained stably severe and required continuous medical supervision. This case emphasizes the importance of early diagnosis, ongoing multidisciplinary management, and clinical vigilance in children with rare neurodegenerative disorders.

About the Authors

Yu. V. Bykov
Stavropol State Medical University; Stavropol Regional Children's Clinical Hospital
Russian Federation

Bykov Yu.V., Candidate of Medical Sciences, Assistant of the Department of Anesthesiology and Intensive Care with a course of additional professional education 

310 Mira st., Stavropol, 355017;
3 Semashko st., Stavropol, 355002



А. N. Obedin
Stavropol State Medical University; Stavropol Regional Clinical Perinatal Center No. 1
Russian Federation

Obedin А.N., Doctor of Medical Sciences, Head of the Department of Anesthesiology, Intensive Care with the course of additional professional education 

310 Mira st., Stavropol, 355017;
3/1 Semashko st., Stavropol, 355002



А. А. Puchkov
Stavropol Regional Children's Clinical Hospital
Russian Federation

Puchkov А.А., Chief Physician 

3 Semashko st., Stavropol, 355002



References

1. Hatch M.K., Donnelly C., Prasun P. et al. Cockayne syndrome: a pediatric neurodegenerative disorder linking mitochondria to aging. J Neurol Sci. 2024. 457. 122863. DOI: 10.1016/j.jns.2023.122863.

2. Hafsi W., Saleh H.M. Cockayne Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Bookshelf ID: NBK525998.

3. Moriwaki S. Cockayne Syndrome. [Article in Japanese]. Brain Nerve. 2019. 71 (4). 390–393. DOI: 10.11477/mf.1416201282.

4. Xu Y., Wu Z., Liu L. et al. Rat Model of Cockayne Syndrome Neurological Disease. Cell Rep. 2019. 29 (4). 800–809.e5. DOI: 10.1016/j.celrep.2019.09.028.

5. Afonso‑Reis R., Madeira C.R., Brito D.V. et al. Insights Into Cockayne Syndrome Type B: What Underlies Its Pathogenesis? Aging Cell. 2025. e70136. DOI: 10.1111/acel.70136.

6. Karikkineth A.C., Scheibye-Knudsen M., Fivenson E. et al. Cockayne syndrome: Clinical features, model systems and pathways. Ageing Res Rev. 2017. 33. 3–17. DOI: 10.1016/j.arr.2016.08.002.

7. Narayanan D.L., Tuteja M., McIntyre A.D. et al. Clinical and Mutation Spectra of Cockayne Syndrome in India. Neurol India. 2021. 69 (2). 362–366. DOI: 10.4103/0028-3886.314579.

8. Pascucci B., Fragale A., Marabitti V. et al. CSA and CSB play a role in the response to DNA breaks. Oncotarget. 2018. 9 (14). 11581–11591. DOI: 10.18632/oncotarget.24342.

9. Pines A., Dijk M., Makowski M. et al. TRiC controls transcription resumption after UV damage by regulating Cockayne syndrome protein A. Nat Commun. 2018. 9 (1). 1040.

10. Sartorelli J., Travaglini L., Macchiaiolo M. et al. Spectrum of ERCC6-Related Cockayne Syndrome (Type B): From Mild to Severe Forms. Genes (Basel). 2024. 15 (4). 508. DOI: 10.3390/genes15040508.

11. Wang X., Zheng R., Dukhinova M. et al. Perspectives in the investigation of Cockayne syndrome group B neurological disease: the utility of patient-derived brain organoid models. J Zhejiang Univ Sci B. 2024. 25 (10). 878–889. DOI: 10.1631/jzus.B2300712.

12. Laugel V., Adam M.P., Feldman J. et al. Cockayne Syndrome. In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle. 2024. Bookshelf ID: NBK1342.

13. Ben Chehida A., Ghali N., Ben Abdelaziz R. et al. Renal Involvement in 2 Siblings With Cockayne Syndrome. Iran J Kidney Dis. 2017. 11 (3). 253–255. DOI: 10.1038/s41431-017-0009-y.

14. Serrano C.A., Morán V., Diez P. Cockayne syndrome. Bol Med Hosp Infant Mex. 2015. 72 (4). 276–283.


Review

For citations:


Bykov Yu.V., Obedin А.N., Puchkov А.А. COCKAYNE SYNDROME TYPE II. Transbaikalian Medical Bulletin. 2025;(4):147-156. (In Russ.) https://doi.org/10.52485/19986173_2025_4_147

Views: 197

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1998-6173 (Online)